To further establish a link between ATX and NF-κB, we measured the expression of RELA after ATX inhibition in mice with IOA-289, which is now in a Phase 1B trial for treating pancreatic cancer. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.